Genomic and personalized medicine: foundations and applications, Translational Research, vol.154, issue.6, pp.277-287, 2009. ,
Preparing for precision medicine, New England Journal of Medicine, vol.366, pp.489-491, 2012. ,
Interactome networks and human disease, Cell, vol.144, issue.6, pp.986-998, 2011. ,
What are Biomarkers?, Current Opinion in HIV and AIDS, vol.5, issue.6, pp.463-466, 2011. ,
Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review, Pharmacology and Therapeutics, vol.138, issue.3, pp.333-408, 2013. ,
Edgetic perturbation models of human inherited disorders, Molecular Systems Biology, vol.5, issue.321, p.321, 2009. ,
Kinome-wide decoding of network-attacking mutations rewiring cancer signaling, Cell, vol.163, issue.1, pp.202-217, 2015. ,
Homeostasis and differentiation in random genetic control networks, Nature, vol.224, pp.177-178, 1969. ,
Boolean formalization of genetic control circuits, Journal of Theoretical Biology, vol.42, issue.3, pp.563-585, 1973. ,
On the natural classification of arguments, Proceedings of the American Academy of Arts and Sciences, vol.7, pp.261-287, 1867. ,
On cores and prime implicants of truth functions, The American Mathematical Monthly, vol.66, issue.9, pp.755-760, 1959. ,
Extending abduction from propositional logic to first order logic, Lecture Notes in Artificial Intelligence, vol.535, pp.141-155, 1991. ,
Cancer therapy design based on pathway logic, Bioinformatics, vol.27, issue.4, pp.548-555, 2011. ,
Application of Max-SAT-based ATPG to optimal cancer therapy design, BMC Genomics, vol.13, issue.6, p.5, 2012. ,
Identification of control targets in boolean molecular network models via computational algebra, BMC Systems Biology, vol.10, issue.1, p.94, 2016. ,
Cell fate reprogramming by control of intracellular network dynamics, PLoS Computational Biology, vol.11, issue.4, p.1004193, 2015. ,
Abductive network action inference for targeted therapy, Electronic Notes in Theoretical Computer Science, vol.335, pp.3-25, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01779429
Computing prime implicants by integer programming, Proceedings Eighth IEEE International Conference on Tools with Artificial Intelligence, pp.332-336, 1996. ,
An introduction to zero-suppressed binary decision diagrams, Proceedings of the 12th Symposium on the Integration of Symbolic Computation and Mechanized Reasoning, vol.8, pp.1-15, 2001. ,
Lecture notes for 49285 Advanced Algorithms E97, available online, 1997. ,
Graph-based algorithms for boolean function manipulation, IEEE Transactions on Computers, vol.100, issue.8, pp.677-691, 1986. ,
Hallmarks of cancer: the next generation, Cell, vol.144, issue.5, pp.646-674, 2011. ,
The dynamic control of signal transduction networks in cancer cells, Nature Reviews Cancer, 2015. ,
BRCA1 and BRCA2: 1994 and beyond, Nature Reviews Cancer, vol.4, issue.9, pp.665-676, 2004. ,
Steady states and oscillations in the p53/Mdm2 network, Cell Cycle, vol.4, issue.3, pp.488-493, 2005. ,
Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines, BMC Systems Biology, vol.8, issue.1, p.75, 2014. ,
KEGG: new perspectives on genomes, pathways, diseases and drugs, Nucleic Acids Research, vol.45, issue.D1, pp.353-361, 2017. ,
SIGNOR: A database of causal relationships between biological entities, Nucleic Acids Research, vol.44, issue.D1, pp.548-554, 2016. ,
Abduction based drug target discovery using boolean control network, Proceedings Computational Methods in Systems Biology -15th International Conference, pp.57-73, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01522072
Cyclin D1 is a nuclear protein required for cell cycle progression in G1, Genes & Development, vol.7, issue.5, pp.812-821, 1993. ,
Molecular signaling in death receptor and mitochondrial pathways of apoptosis, International Journal of Oncology, vol.22, issue.1, pp.15-20, 2003. ,
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy, Breast Cancer Research, vol.16, issue.6, p.485, 2014. ,
Models, mechanisms and clinical evidence for cancer dormancy, Nature Reviews Cancer, vol.7, issue.11, p.834, 2007. ,
Mutational landscape and significance across 12 major cancer types, Nature, vol.502, issue.7471, pp.333-339, 2013. ,
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice, Breast Cancer Research, vol.13, issue.2, p.30, 2011. ,
Oncogenes and cancer, New England Journal of Medicine, vol.358, issue.5, p.18234754, 2008. ,
Molecular cell biology, Biochemistry and Molecular Biology Education, vol.29, pp.126-133, 2001. ,
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy, Nature, vol.434, issue.7035, pp.917-921, 2005. ,
PARP inhibitors in the management of breast cancer: current data and future prospects, BMC Medicine, vol.13, issue.1, p.1, 2015. ,
The concept of synthetic lethality in the context of anticancer therapy, Nature Reviews Cancer, vol.5, issue.9, pp.689-98, 2005. ,
,
The impact of concomitant genomic alterations on treatment outcome for trastuzumab therapy in HER2-positive gastric cancer, Scientific Reports, vol.5, p.9289, 2015. ,
Mechanism of resistance and novel targets mediating resistance to EGFR and c-Met tyrosine kinase inhibitors in non-small cell lung cancer, PloS One, vol.10, issue.8, p.136155, 2015. ,
Widespread genetic epistasis among cancer genes, Nature Communications, vol.5, 2014. ,
Epistasis -the essential role of gene interactions in the structure and evolution of genetic systems, Nature Reviews Genetics, vol.9, issue.11, pp.855-867, 2008. ,
Cancer genome landscapes, Science, vol.339, issue.6127, pp.1546-1558, 2013. ,